Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 39% ± 13% | |
brain | 18 studies | 42% ± 19% | |
lung | 17 studies | 25% ± 7% | |
eye | 9 studies | 34% ± 12% | |
intestine | 8 studies | 23% ± 8% | |
kidney | 5 studies | 27% ± 8% | |
heart | 5 studies | 33% ± 8% | |
lymph node | 5 studies | 31% ± 13% | |
liver | 5 studies | 34% ± 11% | |
pancreas | 4 studies | 25% ± 5% | |
bone marrow | 4 studies | 30% ± 10% | |
uterus | 4 studies | 24% ± 9% | |
breast | 4 studies | 23% ± 3% | |
adipose | 4 studies | 40% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2684.62 | 245 / 245 | 100% | 8.97 | 502 / 502 |
esophagus | 100% | 2020.19 | 1444 / 1445 | 100% | 6.90 | 183 / 183 |
breast | 100% | 2622.23 | 459 / 459 | 100% | 10.59 | 1117 / 1118 |
uterus | 100% | 3329.85 | 170 / 170 | 100% | 6.89 | 457 / 459 |
ovary | 100% | 2926.39 | 180 / 180 | 100% | 8.30 | 428 / 430 |
thymus | 100% | 2749.95 | 653 / 653 | 100% | 10.20 | 602 / 605 |
lung | 100% | 2016.27 | 577 / 578 | 100% | 6.97 | 1151 / 1155 |
brain | 99% | 1570.18 | 2628 / 2642 | 100% | 10.39 | 705 / 705 |
intestine | 100% | 2511.35 | 966 / 966 | 99% | 6.53 | 524 / 527 |
stomach | 100% | 1538.63 | 359 / 359 | 99% | 7.01 | 284 / 286 |
bladder | 100% | 2767.62 | 21 / 21 | 99% | 6.16 | 498 / 504 |
pancreas | 100% | 1115.20 | 327 / 328 | 99% | 7.10 | 176 / 178 |
adrenal gland | 100% | 1360.13 | 258 / 258 | 96% | 5.30 | 221 / 230 |
kidney | 100% | 1372.87 | 89 / 89 | 93% | 6.88 | 841 / 901 |
skin | 100% | 2085.82 | 1809 / 1809 | 92% | 5.50 | 435 / 472 |
liver | 100% | 976.36 | 226 / 226 | 92% | 4.42 | 373 / 406 |
adipose | 100% | 2464.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2209.62 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.62 | 29 / 29 |
spleen | 100% | 2470.94 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.34 | 1 / 1 |
muscle | 100% | 2038.06 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1201.66 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 1477.80 | 871 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 4.59 | 68 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_2000779 | Biological process | regulation of double-strand break repair |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0035092 | Biological process | sperm DNA condensation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0007286 | Biological process | spermatid development |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0000786 | Cellular component | nucleosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035267 | Cellular component | NuA4 histone acetyltransferase complex |
GO_0032777 | Cellular component | piccolo histone acetyltransferase complex |
GO_0016604 | Cellular component | nuclear body |
GO_0005737 | Cellular component | cytoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0140767 | Molecular function | enzyme-substrate adaptor activity |
GO_0140463 | Molecular function | chromatin-protein adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EPC1 |
Protein name | Enhancer of polycomb homolog 1 Enhancer of polycomb homolog |
Synonyms | |
Description | FUNCTION: Component of the NuA4 histone acetyltransferase (HAT) complex, a multiprotein complex involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A . The NuA4 complex plays a direct role in repair of DNA double-strand breaks (DSBs) by promoting homologous recombination (HR) . The NuA4 complex is also required for spermatid development by promoting acetylation of histones: histone acetylation is required for histone replacement during the transition from round to elongating spermatids (By similarity). In the NuA4 complex, EPC1 is required to recruit MBTD1 into the complex . . |
Accessions | ENST00000469059.2 ENST00000263062.8 [Q9H2F5-1] Q9H2F5 ENST00000667706.1 ENST00000319778.11 [Q9H2F5-2] A0A590UJ89 A0A590UJ87 ENST00000480402.1 ENST00000375110.6 [Q9H2F5-3] A0A590UJN0 |